[1]
Forstenpointner J, Rice ASC, Finnerup NB, Baron R. Up-date on Clinical Management of Postherpetic Neuralgia and Mechanism-Based Treatment: New Options in Therapy. The Journal of infectious diseases. 2018 Sep 22:218(suppl_2):S120-S126. doi: 10.1093/infdis/jiy381. Epub
[PubMed PMID: 30247597]
[2]
Lu WH, Lin CW, Wang CY, Chen LK, Hsiao FY. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study. BMC public health. 2018 Mar 20:18(1):369. doi: 10.1186/s12889-018-5247-6. Epub 2018 Mar 20
[PubMed PMID: 29554872]
[3]
Gabutti G, Valente N, Kuhdari P, Lupi S, Stefanati A. Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. Journal of medical microbiology. 2016 Dec:65(12):1363-1369. doi: 10.1099/jmm.0.000386. Epub 2016 Nov 4
[PubMed PMID: 27902409]
[4]
Zorzoli E, Pica F, Masetti G, Franco E, Volpi A, Gabutti G. Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies. Aging clinical and experimental research. 2018 Jul:30(7):693-702. doi: 10.1007/s40520-018-0956-3. Epub 2018 May 2
[PubMed PMID: 29721782]
[5]
Schutzer-Weissmann J, Farquhar-Smith P. Post-herpetic neuralgia - a review of current management and future directions. Expert opinion on pharmacotherapy. 2017 Nov:18(16):1739-1750. doi: 10.1080/14656566.2017.1392508. Epub 2017 Oct 26
[PubMed PMID: 29025327]
Level 3 (low-level) evidence
[6]
Delaney A, Colvin LA, Fallon MT, Dalziel RG, Mitchell R, Fleetwood-Walker SM. Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2009 Oct:6(4):630-7. doi: 10.1016/j.nurt.2009.07.005. Epub
[PubMed PMID: 19789068]
[7]
Hicks LD, Cook-Norris RH, Mendoza N, Madkan V, Arora A, Tyring SK. Family history as a risk factor for herpes zoster: a case-control study. Archives of dermatology. 2008 May:144(5):603-8. doi: 10.1001/archderm.144.5.603. Epub
[PubMed PMID: 18490586]
Level 2 (mid-level) evidence
[8]
Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ (Clinical research ed.). 2000 Sep 30:321(7264):794-6
[PubMed PMID: 11009518]
[9]
Chen F, Chen F, Shang Z, Shui Y, Wu G, Liu C, Lin Z, Lin Y, Yu L, Kang D, Tao W, Li Y. White matter microstructure degenerates in patients with postherpetic neuralgia. Neuroscience letters. 2017 Aug 24:656():152-157. doi: 10.1016/j.neulet.2017.07.023. Epub 2017 Jul 17
[PubMed PMID: 28729077]
Level 3 (low-level) evidence
[10]
Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain. 1991 Feb:44(2):105-117. doi: 10.1016/0304-3959(91)90124-G. Epub
[PubMed PMID: 1711192]
Level 3 (low-level) evidence
[11]
Werner RN, Nikkels AF, Marinović B, Schäfer M, Czarnecka-Operacz M, Agius AM, Bata-Csörgő Z, Breuer J, Girolomoni G, Gross GE, Langan S, Lapid-Gortzak R, Lesser TH, Pleyer U, Sellner J, Verjans GM, Wutzler P, Dressler C, Erdmann R, Rosumeck S, Nast A. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017 Jan:31(1):9-19. doi: 10.1111/jdv.13995. Epub 2016 Nov 2
[PubMed PMID: 27804172]
Level 3 (low-level) evidence
[12]
Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review. Indian journal of dermatology, venereology and leprology. 2018 May-Jun:84(3):251-262. doi: 10.4103/ijdvl.IJDVL_1021_16. Epub
[PubMed PMID: 29516900]
[13]
Gilden D, Nagel MA, Mahalingam R, Mueller NH, Brazeau EA, Pugazhenthi S, Cohrs RJ. Clinical and molecular aspects of varicella zoster virus infection. Future neurology. 2009 Jan 1:4(1):103-117
[PubMed PMID: 19946620]
[14]
Spiegel R, Miron D, Lumelsky D, Horovitz Y. Severe meningoencephalitis due to late reactivation of Varicella-Zoster virus in an immunocompetent child. Journal of child neurology. 2010 Jan:25(1):87-90. doi: 10.1177/0883073809336296. Epub 2009 Jun 3
[PubMed PMID: 19494359]
[15]
Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM, Shingles Prevention Study Group. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. Journal of medical virology. 2009 Jul:81(7):1310-22. doi: 10.1002/jmv.21506. Epub
[PubMed PMID: 19475609]
[16]
Haanpää M, Dastidar P, Weinberg A, Levin M, Miettinen A, Lapinlampi A, Laippala P, Nurmikko T. CSF and MRI findings in patients with acute herpes zoster. Neurology. 1998 Nov:51(5):1405-11
[PubMed PMID: 9818869]
[17]
Lang PO, Ferahta N. [Recommendations for treatment and prevention of herpes zoster and associated pain in aged adults]. La Revue de medecine interne. 2016 Jan:37(1):35-42. doi: 10.1016/j.revmed.2015.08.009. Epub 2015 Sep 14
[PubMed PMID: 26383768]
[18]
Kim SR, Khan F, Ramirez-Fort MK, Downing C, Tyring SK. Varicella zoster: an update on current treatment options and future perspectives. Expert opinion on pharmacotherapy. 2014 Jan:15(1):61-71. doi: 10.1517/14656566.2014.860443. Epub 2013 Nov 30
[PubMed PMID: 24289750]
Level 3 (low-level) evidence
[19]
Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgraduate medicine. 2011 Sep:123(5):134-42. doi: 10.3810/pgm.2011.09.2469. Epub
[PubMed PMID: 21904096]
[20]
Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002 Oct 8:59(7):1015-21
[PubMed PMID: 12370455]
Level 1 (high-level) evidence
[21]
Shrestha M, Chen A. Modalities in managing postherpetic neuralgia. The Korean journal of pain. 2018 Oct:31(4):235-243. doi: 10.3344/kjp.2018.31.4.235. Epub 2018 Oct 1
[PubMed PMID: 30310548]
[22]
Baron R, Allegri M, Correa-Illanes G, Hans G, Serpell M, Mick G, Mayoral V. The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use. Pain and therapy. 2016 Dec:5(2):149-169
[PubMed PMID: 27822619]
[23]
Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. The Cochrane database of systematic reviews. 2017 Jan 13:1(1):CD007393. doi: 10.1002/14651858.CD007393.pub4. Epub 2017 Jan 13
[PubMed PMID: 28085183]
Level 1 (high-level) evidence
[24]
Goncalves D, Rebelo V, Barbosa P, Gomes A. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain. Pain physician. 2020 Sep:23(5):E541-E548
[PubMed PMID: 32967405]
[25]
Kim YH, Lee PB, Oh TK. Is magnesium sulfate effective for pain in chronic postherpetic neuralgia patients comparing with ketamine infusion therapy? Journal of clinical anesthesia. 2015 Jun:27(4):296-300. doi: 10.1016/j.jclinane.2015.02.006. Epub 2015 Mar 17
[PubMed PMID: 25792176]
[26]
Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. Journal of pain and symptom management. 1999 Jun:17(6):429-33
[PubMed PMID: 10388248]
[27]
Apalla Z, Sotiriou E, Lallas A, Lazaridou E, Ioannides D. Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial. The Clinical journal of pain. 2013 Oct:29(10):857-64. doi: 10.1097/AJP.0b013e31827a72d2. Epub
[PubMed PMID: 23370074]
Level 1 (high-level) evidence
[28]
Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. The New England journal of medicine. 2014 Oct 16:371(16):1526-33. doi: 10.1056/NEJMcp1403062. Epub
[PubMed PMID: 25317872]